7Baggers
 published on: 2025-09-29 13:17:25  newser.com Mon, 29 Sep 2025 18:17:25 GMT
 Published on: 2025-09-29 06:21:35  newser.com Mon, 29 Sep 2025 11:21:35 GMT
 Published on: 2025-09-29 05:14:33  newser.com Mon, 29 Sep 2025 10:14:33 GMT
 delisting of securities from the nasdaq stock market  The Globe and Mail Wed, 24 Sep 2025 11:20:00 GMT
 published on: 2025-09-21 05:37:16  newser.com Sun, 21 Sep 2025 10:37:16 GMT
 ZyVersa Therapeutics Faces Nasdaq Delisting Notice  TipRanks Thu, 18 Sep 2025 07:00:00 GMT
 published on: 2025-09-13 10:45:06  newser.com Sat, 13 Sep 2025 15:45:06 GMT
 published on: 2025-09-11 23:58:26  Newser Fri, 12 Sep 2025 04:58:26 GMT
 published on: 2025-09-09 05:07:51  Newser Tue, 09 Sep 2025 10:07:51 GMT
 published on: 2025-09-06 13:46:53  Newser Sat, 06 Sep 2025 18:46:53 GMT
 published on: 2025-09-05 23:28:55  خودرو بانک Fri, 05 Sep 2025 20:58:45 GMT
 published on: 2025-09-05 14:22:44  Newser Fri, 05 Sep 2025 19:22:44 GMT
 published on: 2025-09-04 22:37:58  Newser Fri, 05 Sep 2025 03:37:58 GMT
 published on: 2025-09-04 10:00:53  Newser Thu, 04 Sep 2025 15:00:53 GMT
 published on: 2025-09-03 02:18:08  Newser Wed, 03 Sep 2025 07:18:08 GMT
 ZyVersa Therapeutics Highlights Lipidomic Data in Alport  GlobeNewswire Wed, 03 Sep 2025 07:00:00 GMT
 published on: 2025-09-02 13:47:22  Newser Tue, 02 Sep 2025 18:47:22 GMT

ZyVersa Therapeutics, Inc.
(NASDAQ:ZVSA) 

ZVSA stock logo

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and...

Founded: 2014
Full Time Employees: 6
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends